...
search icon
cers-img

Cerus Corporation, Common Stock

CERS

NMQ

$1.85

+$0.05

(2.78%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$343.57M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.17M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.20
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.38 L
$2.58 H
$1.85

About Cerus Corporation, Common Stock

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameCERSSectorS&P500
1-Week Return8.19%-0.03%1.53%
1-Month Return6.94%4.56%4.75%
3-Month Return2.78%1.29%2.77%
6-Month Return-10.19%-3.54%12.18%
1-Year Return-20.43%1.59%22.34%
3-Year Return-64.49%13.55%38.91%
5-Year Return-62.24%40.85%80.7%
10-Year Return-66.58%105.52%190.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue74.65M91.92M130.86M162.05M156.37M[{"date":"2019-12-31","value":46.07,"profit":true},{"date":"2020-12-31","value":56.72,"profit":true},{"date":"2021-12-31","value":80.75,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.49,"profit":true}]
Cost of Revenue33.42M41.16M63.48M74.95M69.97M[{"date":"2019-12-31","value":44.59,"profit":true},{"date":"2020-12-31","value":54.91,"profit":true},{"date":"2021-12-31","value":84.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.35,"profit":true}]
Gross Profit41.23M50.76M67.38M87.09M86.40M[{"date":"2019-12-31","value":47.34,"profit":true},{"date":"2020-12-31","value":58.29,"profit":true},{"date":"2021-12-31","value":77.37,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.2,"profit":true}]
Gross Margin55.23%55.23%51.49%53.75%55.25%[{"date":"2019-12-31","value":99.96,"profit":true},{"date":"2020-12-31","value":99.95,"profit":true},{"date":"2021-12-31","value":93.19,"profit":true},{"date":"2022-12-31","value":97.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses107.46M109.10M116.32M121.17M115.34M[{"date":"2019-12-31","value":88.68,"profit":true},{"date":"2020-12-31","value":90.03,"profit":true},{"date":"2021-12-31","value":95.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.18,"profit":true}]
Operating Income(66.23M)(58.33M)(48.94M)(34.08M)(30.05M)[{"date":"2019-12-31","value":-6622600000,"profit":false},{"date":"2020-12-31","value":-5833300000,"profit":false},{"date":"2021-12-31","value":-4893600000,"profit":false},{"date":"2022-12-31","value":-3408100000,"profit":false},{"date":"2023-12-31","value":-3005300000,"profit":false}]
Total Non-Operating Income/Expense(10.82M)(4.99M)(10.04M)(14.09M)(15.12M)[{"date":"2019-12-31","value":-1082000000,"profit":false},{"date":"2020-12-31","value":-498600000,"profit":false},{"date":"2021-12-31","value":-1004400000,"profit":false},{"date":"2022-12-31","value":-1408700000,"profit":false},{"date":"2023-12-31","value":-1512300000,"profit":false}]
Pre-Tax Income(70.98M)(59.57M)(54.06M)(42.34M)(37.32M)[{"date":"2019-12-31","value":-7098100000,"profit":false},{"date":"2020-12-31","value":-5957300000,"profit":false},{"date":"2021-12-31","value":-5405700000,"profit":false},{"date":"2022-12-31","value":-4233700000,"profit":false},{"date":"2023-12-31","value":-3732200000,"profit":false}]
Income Taxes263.00K284.00K319.00K488.00K325.00K[{"date":"2019-12-31","value":53.89,"profit":true},{"date":"2020-12-31","value":58.2,"profit":true},{"date":"2021-12-31","value":65.37,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.6,"profit":true}]
Income After Taxes(71.24M)(59.86M)(54.38M)(42.83M)(37.65M)[{"date":"2019-12-31","value":-7124400000,"profit":false},{"date":"2020-12-31","value":-5985700000,"profit":false},{"date":"2021-12-31","value":-5437600000,"profit":false},{"date":"2022-12-31","value":-4282500000,"profit":false},{"date":"2023-12-31","value":-3764700000,"profit":false}]
Income From Continuous Operations(71.24M)(59.86M)(54.38M)(42.83M)(49.88M)[{"date":"2019-12-31","value":-7124400000,"profit":false},{"date":"2020-12-31","value":-5985700000,"profit":false},{"date":"2021-12-31","value":-5437600000,"profit":false},{"date":"2022-12-31","value":-4282500000,"profit":false},{"date":"2023-12-31","value":-4988300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(71.24M)(59.86M)(54.38M)(42.83M)(37.49M)[{"date":"2019-12-31","value":-7124400000,"profit":false},{"date":"2020-12-31","value":-5985700000,"profit":false},{"date":"2021-12-31","value":-5437600000,"profit":false},{"date":"2022-12-31","value":-4282500000,"profit":false},{"date":"2023-12-31","value":-3748900000,"profit":false}]
EPS (Diluted)(0.52)(0.36)(0.31)(0.25)(0.19)[{"date":"2019-12-31","value":-52,"profit":false},{"date":"2020-12-31","value":-36,"profit":false},{"date":"2021-12-31","value":-31,"profit":false},{"date":"2022-12-31","value":-25,"profit":false},{"date":"2023-12-31","value":-19,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CERS
Cash Ratio 1.39
Current Ratio 2.59
Quick Ratio 1.92

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CERS
ROA (LTM) -3.73%
ROE (LTM) -38.31%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CERS
Debt Ratio Lower is generally better. Negative is bad. 0.71
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.28

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CERS
Trailing PE NM
Forward PE NM
P/S (TTM) 1.95
P/B 6.25
Price/FCF 103
EV/R 2.02
EV/Ebitda NM
PEG NM

FAQs

What is Cerus Corporation share price today?

Cerus Corporation (CERS) share price today is $1.85

Can Indians buy Cerus Corporation shares?

Yes, Indians can buy shares of Cerus Corporation (CERS) on Vested. To buy Cerus Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CERS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cerus Corporation be purchased?

Yes, you can purchase fractional shares of Cerus Corporation (CERS) via the Vested app. You can start investing in Cerus Corporation (CERS) with a minimum investment of $1.

How to invest in Cerus Corporation shares from India?

You can invest in shares of Cerus Corporation (CERS) via Vested in three simple steps:

  • Click on Sign Up or Invest in CERS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Cerus Corporation shares
What is Cerus Corporation 52-week high and low stock price?

The 52-week high price of Cerus Corporation (CERS) is $2.58. The 52-week low price of Cerus Corporation (CERS) is $1.38.

What is Cerus Corporation price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cerus Corporation (CERS) is 6.25

What is the Market Cap of Cerus Corporation?

The market capitalization of Cerus Corporation (CERS) is $343.57M

What is Cerus Corporation’s stock symbol?

The stock symbol (or ticker) of Cerus Corporation is CERS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top